Radiographic Progression-Free Survival and Overall Survival Correlation in TALAPRO-2 - Neeraj Agarwal
Neeraj Agarwal
Neeraj Agarwal presents a correlation analysis from TALAPRO-2 examining whether radiographic progression-free survival predicts overall survival in the phase 3 trial of enzalutamide plus talazoparib in first-line mCRPC.
Doublet Versus Triplet Intensification in Metastatic Hormone-Sensitive Prostate Cancer - Jacqueline Brown
Jacqueline Brown
Jacqueline Brown discusses doublet versus triplet therapy in metastatic hormone-sensitive prostate cancer with Neeraj Agarwal, drawing on her AUA 2026 presentation.
